Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 122 entries
Sorted by: Best Match Show Resources per page
Corrigendum: mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases.

Nature communications

Palmieri M, Pal R, Nelvagal HR, Lotfi P, Stinnett GR, Seymour ML, Chaudhury A, Bajaj L, Bondar VV, Bremner L, Saleem U, Tse DY, Sanagasetti D, Wu SM, Neilson JR, Pereira FA, Pautler RG, Rodney GG, Cooper JD, Sardiello M.
PMID: 28607479
Nat Commun. 2017 Jun 13;8:15793. doi: 10.1038/ncomms15793.

This corrects the article DOI: 10.1038/ncomms14338.

Poly(alkyl methacrylate) Brush-Grafted Silica Nanoparticles as Oil Lubricant Additives: Effects of Alkyl Pendant Groups on Oil Dispersibility, Stability, and Lubrication Property.

ACS applied materials & interfaces

Seymour BT, Wright RAE, Parrott AC, Gao H, Martini A, Qu J, Dai S, Zhao B.
PMID: 28670899
ACS Appl Mater Interfaces. 2017 Jul 26;9(29):25038-25048. doi: 10.1021/acsami.7b06714. Epub 2017 Jul 12.

This article reports on the synthesis of a series of poly(alkyl methacrylate) brush-grafted, 23 nm silica nanoparticles (hairy NPs) and the study of the effect of alkyl pendant length on their use as oil lubricant additives for friction and...

A C. R. L. down under.

Hospital progress

SEYMOUR L.
PMID: 13672577
Hosp Prog. 1959 Jul;40(7):38.

No abstract available.

Health, wealth and the pursuit of happiness.

The journal of the Royal Society for the Promotion of Health

Seymour L.
PMID: 17402310
J R Soc Promot Health. 2007 Mar;127(2):61-2. doi: 10.1177/1466424007075451.

No abstract available.

Need for global partnership in cancer care: perceptions of cancer care researchers attending the 2010 australia and Asia pacific clinical oncology research development workshop.

Journal of oncology practice

Lyerly HK, Abernethy AP, Stockler MR, Koczwara B, Aziz Z, Nair R, Seymour L.
PMID: 22211131
J Oncol Pract. 2011 Sep;7(5):324-9. doi: 10.1200/JOP.2011.000230. Epub 2011 Aug 04.

PURPOSE: To understand the diversity of issues and the breadth of growing clinical care, professional education, and clinical research needs of developing countries, not typically represented in Western or European surveys of cancer care and research.METHODS: A cross-sectional survey...

Simple x-ray standing-wave technique and its application to the investigation of the Cu(111) ( sqrt 3 sqrt 3 )R30 degrees -Cl structure.

Physical review letters

Crapper MD, Jones RG, McConville CF, Prince NP, Riley CE, Seymour DL, Woodruff DP.
PMID: 10034442
Phys Rev Lett. 1987 Apr 06;58(14):1460-1462. doi: 10.1103/PhysRevLett.58.1460.

No abstract available.

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness.

Critical care (London, England)

Seymour CW, Gomez H, Chang CH, Clermont G, Kellum JA, Kennedy J, Yende S, Angus DC.
PMID: 29047353
Crit Care. 2017 Oct 18;21(1):257. doi: 10.1186/s13054-017-1836-5.

All of medicine aspires to be precise, where a greater understanding of individual data will lead to personalized treatment and improved outcomes. Prompted by specific examples in oncology, the field of critical care may be tempted to envision that...

A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.

Oncotarget

Leighl NB, Tsao MS, Liu G, Tu D, Ho C, Shepherd FA, Murray N, Goffin JR, Nicholas G, Sakashita S, Chen Z, Kim L, Powers J, Seymour L, Goss G, Bradbury PA.
PMID: 29050231
Oncotarget. 2017 Jun 28;8(41):69651-69662. doi: 10.18632/oncotarget.18753. eCollection 2017 Sep 19.

PURPOSE: MET and AXL mediate resistance to EGFR TKI in NSCLC. Foretinib, a MET/RON/AXL/TIE-2/VEGFR kinase inhibitor may overcome EGFR kinase resistance. This dose escalation study combined foretinib and erlotinib in advanced pretreated NSCLC patients.EXPERIMENTAL DESIGN: The primary endpoint was...

Google Search Trends in Oncology and the Impact of Celebrity Cancer Awareness.

Cureus

Kaleem T, Malouff TD, Stross WC, Waddle MR, Miller DH, Seymour AL, Zaorsky NG, Miller RC, Trifiletti DM, Vallow L.
PMID: 31608195
Cureus. 2019 Aug 10;11(8):e5360. doi: 10.7759/cureus.5360.

Introduction There is widespread public interest when celebrities are diagnosed with cancer. We sought to assess how this interest impacts awareness of prevalent cancers. Methods We reviewed common cancer-related search terms using Google Trends (Google LLC, Mountain View, CA)...

Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care: NHLBI Working Group Report.

American journal of respiratory and critical care medicine

Semler MW, Bernard GR, Aaron SD, Angus DC, Biros MH, Brower RG, Calfee CS, Colantuoni EA, Ferguson ND, Gong MN, Hopkins RO, Hough CL, Iwashyna TJ, Levy BD, Martin TR, Matthay MA, Mizgerd JP, Moss M, Needham DM, Self WH, Seymour CW, Stapleton RD, Thompson BT, Wunderink RG, Aggarwal NR, Reineck LA.
PMID: 32150460
Am J Respir Crit Care Med. 2020 Mar 09; doi: 10.1164/rccm.201908-1595WS. Epub 2020 Mar 09.

Preventing, treating, and promoting recovery from critical illness due to pulmonary disease are foundational goals of the critical care community and the National Heart, Lung, and Blood Institute. Decades of clinical research in acute respiratory distress syndrome, acute respiratory...

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy.

Cancers

Hao D, Sengupta A, Ding K, Ubeydullah ER, Krishnaiah S, Leighl NB, Shepherd FA, Seymour L, Weljie A.
PMID: 32708705
Cancers (Basel). 2020 Jul 16;12(7). doi: 10.3390/cancers12071926.

The metabolic requirements of metastatic non-small cell lung (mNSCLC) tumors from patients receiving first-line platinum-doublet chemotherapy are hypothesized to imprint a blood signature suitable for survival prediction. Pre-treatment samples prospectively collected at baseline from a randomized phase III trial...

Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease.

Antioxidants (Basel, Switzerland)

Nuhu F, Seymour AM, Bhandari S.
PMID: 31640237
Antioxidants (Basel). 2019 Oct 21;8(10). doi: 10.3390/antiox8100498.

BACKGROUND: Mitochondrial dysfunction is observed in chronic kidney disease (CKD). Iron deficiency anaemia (IDA), a common complication in CKD, is associated with poor clinical outcomes affecting mitochondrial function and exacerbating oxidative stress. Intravenous (iv) iron, that is used to...

Showing 1 to 12 of 122 entries